Location of Repository

Breast cancer patients diagnosed by National Breast Screening Programme

By Sarah Ellul, Kay Vanhear, Ramona Camilleri and Gordon Caruana Dingli

Abstract

Breast cancer is the most common cancer in Malta. A National Breast Screening Programme (NBSP) was introduced in 2009 for women in the 50 to 60 year old age group. The first 112 patients diagnosed by the NBSP were compared to a matched control group of symptomatic patients randomly selected from the Breast Clinic, who had presented to the clinic with a breast lump. The files of all these patients were reviewed retrospectively. In the screening group there were 94 patients with invasive cancer and 18 patients with ductal carcinoma in situ (DCIS) while in the control group there were 114 patients with invasive cancer and 3 with DCIS. In the screening group, 81 (86.2%) patients with invasive cancer underwent wide local excision (WLE) and 13 (13.8%) underwent mastectomy. In the control group 88 (77.2%) patients with invasive cancer underwent WLE and 26 (22.8%) had a mastectomy. Out of all the patients in the screened group with DCIS, 12 (66.7%) underwent WLE and 6 (33.3%) underwent mastectomy. In the control group only 3 patients had DCIS and these were all treated by WLE. The average Nottingham Prognostic Index (NPI) of the screening population with invasive cancer is (3.28 (95% CI)) and is lower than the NPI of the control group is (3.74 (95% CI)). This study shows that in the screening group there is a higher percentage of patients with DCIS when compared to the control group. Furthermore, the screened group patients with DCIS were more likely to undergo mastectomy than those with invasive cancer.peer-reviewe

Topics: Cancer -- Prevention, Mastectomy -- Malta, Medical screening -- Malta, Breast -- Cancer -- Diagnosis -- Malta
Publisher: Malta Medical Journal
Year: 2015
OAI identifier: oai:www.um.edu.mt:123456789/8222
Provided by: OAR@UM

Suggested articles

Preview

Citations

  1. (2014). Action for Breast Cancer Foundation: Available at http://www.actionforbreastcancer.com/about-abcf/.
  2. (2010). Breast cancer in Malta – a comparative study between the year 2000 and
  3. (2010). Breast cancer precursors revisited: molecular features and progression pathways. Histopathology doi
  4. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. doi
  5. (2002). IARC: Handbooks of Cancer Prevention-Breast Cancer Screening Volume 7. France; doi
  6. (2015). Improved survival for screen-detected breast cancer: Available at http://www.ncin.org.uk/publications/data_briefings/improved_s urvival_for_screen_detected_breast_cancer.
  7. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. doi
  8. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 2011;260;621- doi
  9. (2014). Malta: Available at http://www.europadonnamalta.org.mt/index.php?p=about.
  10. (2009). Overdiagnosis and mammography screening. BMJ doi
  11. (2013). Progression from ductal carcinoma in situ to invasive breast cancer: Revisited. Mol Oncol doi
  12. (2015). Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;1;CD001877. doi
  13. (2014). Screening: Available at http://maltabreastscreening.info/.
  14. (2002). Twenty-Year Follow-up of a Randomized Study Comparing Breast- Conserving Surgery with Radical Mastectomy for Early Breast Cancer. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.